Noninvasive visualization of pharmacokinetics, biodistribution and tumor targeting of poly[N-(2-hydroxypropyl)methacrylamide] in mice using contrast enhanced MRI
- PMID: 17387601
- DOI: 10.1007/s11095-007-9252-1
Noninvasive visualization of pharmacokinetics, biodistribution and tumor targeting of poly[N-(2-hydroxypropyl)methacrylamide] in mice using contrast enhanced MRI
Abstract
Purpose: To study a non-invasive method of using contrast enhanced magnetic resonance imaging (MRI) to visualize the real-time pharmacokinetics, biodistribution and tumor accumulation of paramagnetically labeled poly[N-(2-hydroxypropyl)methacrylamide] (PHPMA) copolymer conjugates with different molecular weights and spacers in tumor-bearing mice.
Materials and methods: Paramagnetically labeled HPMA copolymer conjugates were synthesized by free radical copolymerization of HPMA with monomers containing a chelating ligand, followed by complexation with Gd(OAc)(3). A stable paramagnetic chelate, Gd-DO3A, was conjugated to the copolymers via a degradable spacer GlyPheLeuGly and a non-degradable spacer GlyGly, respectively. The conjugates with molecular weights of 28, 60 and 121 kDa and narrow molecular weight distributions were prepared by fractionation with size exclusion chromatography. The conjugates were injected into athymic nude mice bearing MDA-MB-231 human breast carcinoma xenografts via a tail vein. MR images were acquired before and at various time points after the injection with a 3D FLASH sequence and a 2D spin-echo sequence at 3T. Pharmacokinetics, biodistribution and tumor accumulation of the conjugates were visualized based on the contrast enhancement in the blood, major organs and tumor tissue at various time points. The size effect of the conjugates was analyzed among the conjugates.
Results: Contrast enhanced MRI resulted in a real-time, three-dimensional visualization of blood circulation, pharmacokinetics, biodistribution and tumor accumulation of the conjugates, and the size effect on these pharmaceutical properties. HPMA copolymer conjugates with high molecular weight had a prolonged blood circulation time and high passive tumor targeting efficiency. Non-biodegradable HPMA copolymers with molecular weights higher than the threshold of renal filtration demonstrated higher efficiency for tumor drug delivery than biodegradable poly(L-glutamic acid).
Conclusions: Contrast enhanced MRI is an effective method for non-invasive visualization of in vivo properties of the paramagnetically labeled polymer conjugates in preclinical studies.
Similar articles
-
Noninvasive visualization of in vivo drug delivery of poly(L-glutamic acid) using contrast-enhanced MRI.Mol Pharm. 2006 Sep-Oct;3(5):507-15. doi: 10.1021/mp060052g. Mol Pharm. 2006. PMID: 17009849 Free PMC article.
-
Passive and active hepatoma tumor targeting of new N-(2-hydroxypropyl)methacrylamide copolymer conjugates: synthesis, characterization, and evaluation in vitro and in vivo.J Biomater Sci Polym Ed. 2013;24(12):1472-83. doi: 10.1080/09205063.2013.768944. Epub 2013 Feb 11. J Biomater Sci Polym Ed. 2013. PMID: 23829459
-
Stimuli-responsive biodegradable and gadolinium-based poly[N-(2-hydroxypropyl) methacrylamide] copolymers: their potential as targeting and safe magnetic resonance imaging probes.J Mater Chem B. 2017 Apr 21;5(15):2763-2774. doi: 10.1039/c6tb03253b. Epub 2017 Mar 29. J Mater Chem B. 2017. PMID: 32264163
-
Molecular imaging of HPMA copolymers: visualizing drug delivery in cell, mouse and man.Adv Drug Deliv Rev. 2010 Feb 17;62(2):246-57. doi: 10.1016/j.addr.2009.12.007. Epub 2010 Jan 7. Adv Drug Deliv Rev. 2010. PMID: 20060431 Review.
-
HPMA copolymer-cyclic RGD conjugates for tumor targeting.Adv Drug Deliv Rev. 2010 Feb 17;62(2):167-83. doi: 10.1016/j.addr.2009.11.027. Epub 2009 Dec 4. Adv Drug Deliv Rev. 2010. PMID: 19951733 Review.
Cited by
-
MRI in ocular drug delivery.NMR Biomed. 2008 Nov;21(9):941-56. doi: 10.1002/nbm.1230. NMR Biomed. 2008. PMID: 18186077 Free PMC article. Review.
-
Polymer platforms for drug delivery and biomedical imaging.J Control Release. 2007 Oct 8;122(3):269-77. doi: 10.1016/j.jconrel.2007.06.016. Epub 2007 Jun 27. J Control Release. 2007. PMID: 17662500 Free PMC article.
-
Synthesis and evaluation of globular Gd-DOTA-monoamide conjugates with precisely controlled nanosizes for magnetic resonance angiography.Biomacromolecules. 2008 Oct;9(10):2742-8. doi: 10.1021/bm800486c. Epub 2008 Sep 5. Biomacromolecules. 2008. PMID: 18771313 Free PMC article.
-
Noninvasive monitoring of HPMA copolymer-RGDfK conjugates by magnetic resonance imaging.Pharm Res. 2009 May;26(5):1121-9. doi: 10.1007/s11095-009-9830-5. Epub 2009 Jan 22. Pharm Res. 2009. PMID: 19160028 Free PMC article.
-
Single-shot T1 mapping using simultaneous acquisitions of spin- and stimulated-echo-planar imaging (2D ss-SESTEPI).Magn Reson Med. 2010 Sep;64(3):734-42. doi: 10.1002/mrm.22367. Magn Reson Med. 2010. PMID: 20564579 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous